Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Megan Haggan 19/07/2016

innovation: candle, tungsten bulb, two modern light bulbs

Debbie Rigby takes a look at the latest research pertinent to community pharmacy Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesIn this double-blind trial, liraglutide, an analogue of human glucagon like peptide 1 (GLP-1), showed a lower rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Category killer’ CWH has scope for growth

Easier said than done. I agree with you, but you know how hard it is too.

D vL

‘Category killer’ CWH has scope for growth

You're under no obligation to provide advice on that product. In fact, you probably shouldn't because you have not screened…

Bart Pharm

Did wave of protest fail to break?

Are they? STILL SOLICITING BRIBES!

D vL

Did wave of protest fail to break?

Coles and Woolies have been good for competition? Have you not followed the Senate inquiry into the supermarkets and how…

Bart Pharm

Research Roundup

Previous Ministers welcomed by pharmacy groups

Next Hear this: audio education

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Ministers welcomed by pharmacy groups

Next Hear this: audio education

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.